CD19 hsCAR-T for Refractory/Relapsed CD19+ B-ALL Patients

Clinical trial NCT03902197 · UNKNOWN

Trial details

NCT number: NCT03902197
Sponsor: Xuanwu Hospital, Beijing
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Acute Lymphoblastic Leukemia

Start date: 2019-04-22
Primary completion: 2021-12-31
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.